DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Aesthetic Treatment - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
The Global Non-Invasive Aesthetic Treatment Market is expected to grow at a CAGR of 12.9% during the forecast period. Growing implementation of minimally invasive procedures, acceptance of non-surgical cosmetic procedures and rising wakefulness regarding advanced treatment methods are some of the key driving factors for the market growth. However, high cost associated with the treatment procedures may hinder the market growth.
Non-Invasive Aesthetic Treatment is an extensively broad term for specialties that focus on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration, and spider veins by not involving the introduction of instruments into the body. It does not cut the skin or enter any of the body.
Based on procedure, the skin rejuvenation segment is likely to have a huge demand due to its effectiveness in restoring the patient's youthful appearance through skin alterations. This procedure can do more than avoiding skin aging and stopping premature aging and is therefore getting an increased popularity in the developing countries. By geography, North America is going to have a lucrative growth during the forecast period owing to the growing demand for cosmetic procedures and the high disposable income of consumers.
What the report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Non-Invasive Aesthetic Treatment Market, By Procedure
5.1 Introduction
5.2 Skin Rejuvenation
5.2.1 Laser Skin Resurfacing
5.2.2 Photorejuvenation
5.2.3 Chemical Peel
5.3 Injectables
5.3.1 Calcium Hydroxylapatite
5.3.2 Hyaluronic Acid
5.3.3 Collagen
5.3.4 Botulinum Toxin
5.3.5 Polymer Filler
5.4 Other Procedures
5.4.1 Nonsurgical Fat Reduction
5.4.2 Cellulite Treatment
5.4.3 Hair Removal
5.4.4 Sclerotherapy
6 Global Non-Invasive Aesthetic Treatment Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Medical Spa
6.4 Clinics
6.5 Beauty Centers
6.6 Home Care Setting
6.7 Other End Users
7 Global Non-Invasive Aesthetic Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 South America
7.6 Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Allergan Inc
9.2 Alma Lasers
9.3 Hologic Inc
9.4 Johnson & Johnson
9.5 Galderma S.A.
9.6 Merz Pharma
9.7 Revance Therapeutics Inc
9.8 Solta Medical
9.9 Cutera Inc
9.10 Lumenis
9.11 Syneron Candela
9.12 Vermont Med Spa
9.13 Solta Medical
9.14 Venus Concept
9.15 Anika Therapeutics Inc
9.16 Sinclair Pharma
For more information about this report visit https://www.researchandmarkets.com/r/o425xa
